ACOX1 and obesity due to melanocortin 4 receptor deficiency: Dietary supplementation of ACOX1 inhibitor has the potential to be an effective strategy for treating obesity-associated metabolic disorders (Lu et al., 2024; Shang et al., 2024; Zeng et al., 2017).